Dr. Daniel Sedmak, a professor of pathology and long-time Ohio State doctor, was named the lab's new medical director. He replaces former director Dr. Amy Gewirtz, who will continue her work at the medical center.
The settlement allows the hospital lab's work to continue, said Larry Anstine, CEO of the Ohio State University Hospital.
"Last year the labs performed more than nine million tests and many of those tests are unique and not widely available at other testing facilities," Anstine said in a statement Wednesday. "We are grateful to CMS for its willingness to work toward a resolution that best meets the needs of our patients and the community."
The Centers for Medicare and Medicaid Services declined to comment.
Andrew Welsh-Huggins can be reached on Twitter at https://twitter.com/awhcolumbus.